2024

Cognitive symptoms in schizophrenia

Entrant

Sensu

Category

Video, Commercial & Film - Animation

Client's Name

Boehringer-Ingelheim

Country / Region

Netherlands

Boehringer Ingelheim wanted to explain the molecular intricacies of schizophrenia’s cognitive symptoms while keeping it accessible. They reached out to us for help.Our goal? Make the complex understandable. This case study dives into our process. We tailored each version for different audiences with the goal of fostering widespread awareness and understanding of cognitive symptoms in schizophrenia. In visualising the symptoms of schizophrenia, we drew inspiration from the ink-blotter style of the Rorschach test. By merging ink clouds into short texts, we depicted the challenges faced by individuals living with schizophrenia. This approach fostered inclusivity, enabling viewers to interpret the visualisations through their own experiences.

Provider & Services
2024
Kidney disease guidelines to manage and treat high potassium

Entrant

American Kidney Fund

Category

Provider & Services - Patient Engagement

Country / Region

United States

Technology Solutions
2024
MMIT’s Patient Access Analytics

Entrant

MMIT

Category

Technology Solutions - Healthcare Solution

Country / Region

United States

Video, Commercial & Film
2024
What is IgA nephropathy (IgAN)? | Rare Kidney Disease

Entrant

American Kidney Fund

Category

Video, Commercial & Film - Educational

Country / Region

United States

Website
2024
BoundlessLife

Entrant

Boundless Life Sciences

Category

Website - Marketing

Country / Region

United States